Company intelligence / Profile preview

Charter Research

Lady Lake, Florida, United Statescharterresearch.com ↗

Ownership: Private
Employees: ~102
Development stage: Other

Overview

Charter Research has contributed to pivotal clinical trials leading to FDA approvals, such as the lecanemab (Leqembi) program for Alzheimer’s disease. Their work supports data collection for new therapies in multiple therapeutic areas, with an emphasis on neurodegenerative disorders like Alzheimer’s and Parkinson’s diseases. The company is recognized for high-quality operations and patient care standards, contributing significantly to multi-center global drug development efforts.

Therapeutic areas: Neurology
Modalities: Small moleculeMonoclonal antibody
Industry: Contract Research Organization

Partnerships

EisaiBiogen

Beyond the preview

Go deeper on Charter Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Charter Research.

Explore the full profile